Our Story

Renew is building the next generation of sequencing-driven diagnostics and translational research solutions through native and long-read technologies, transforming genetic, epigenetic, and transcriptomic complexity into clinical products, research assays, and scalable programs designed to improve patient care.
Two scientists in masks discussing data on a computer screen beside a microscope in a lab.
Our Approach
Our approach is rooted in developing technology applications designed to preserve biological signal and expand what can be measured from each sample. By pairing advanced sequencing with specialized preparation, bioinformatics, and clinical execution, Renew builds platforms that are analytically rigorous, scalable, and ready for real-world translation.
Integrity
High standards. In our science, our partnerships, and our communication so that our work is trusted at every level.
Innovation
We challenge assumptions and pursue bold ideas to solve hard problems and push biotechnology forward.
Impact
We focus on delivering meaningful outcomes that advance human health and create lasting value.
Renew Labs
Renew Labs is the engine behind Renew’s innovation, validation, and execution. Across 20,000 square feet of long-read and native-read sequencing infrastructure, CLIA and CAP laboratory systems, high-throughput assay development capacity, and a custom LIMS built in-house, the lab powers next-generation diagnostics and translational sequencing applications across our internal pipeline, partner programs, and client work.
  • Build technologies that reveal more of the biology behind disease
  • Advance native-read diagnostics across genetic, epigenetic, and transcriptomic signals
  • Turn complex molecular data into clinical and research decision tools
  • Move scalable assays from discovery into real-world healthcare
  • Support earlier detection, better stratification, and more personalized care